ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Late Renal Allograft Rejection Is Predicted by High Intrapatient Variability of Tacrolimus Levels.

D. Goodall, M. Willicombe, A. McLean, D. Taube.

Imperial College Renal and Transplant Centre, Imperial College NHS Trust, London, United Kingdom.

Meeting: 2016 American Transplant Congress

Abstract number: D280

Keywords: Kidney transplantation, Pharmacokinetics, Rejection

Session Information

Date: Tuesday, June 14, 2016

Session Name: Poster Session D: Psychosocial and Treatment Adherence

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • High Within-Patient Variability in Tacrolimus Levels Is a Predictor of Late Rejection in Young Adult Kidney Transplant Recipients
  • Intrapatient Variability of Tacrolimus Trough Levels and Outpatient Clinic Non-Attendance Rates Predict Poor Renal Allograft Survival

Introduction

Nonadherence to immunosuppressive medication is associated with rejection and graft loss. We have previously shown that intrapatient variability (IPV) of tacrolimus trough levels between 6-12 months post-transplant can be used as a surrogate marker for adherence and that a high IPV can predict rejection and graft loss. In this study we assess the variability of tacrolimus levels preceding an episode of late first episode rejection (after one year).

Method

We retrospectively analysed 668 patients who received a low risk kidney only transplant between 01/11/2005 and 01/09/2013. Patients who developed rejection in the first year post transplant were excluded. All patients received alemtuzumab induction and tacrolimus monotherapy with a steroid sparing protocol with a target pre-trough tacrolimus level of 5-8ng/ml. Controls were chosen as patients transplanted immediately before and after each rejection case from the overall cohort (N=124). Tacrolimus levels at matched time intervals to the rejection cases were used for analysis.

Results

62 cases of late first rejection episodes were identified. The mean time to rejection was 2.28 ± 1.16 years. Mean follow up 5.65 ± 2.12years

   Rejection  Non-rejection  p value
 IPV pre-rejection**  25.88+/-12.17  22.38+/-9.18  0.0298
 Mean tacrolimus level  6.81+/-1.25  6.89+/-1.21  0.68
 Mean Max tacrolimus level  11.49+/-4.47  10.62+/-3.52  0.15
 Mean Min tacrolimus level  3.96+/-1.23  4.44+/-1.27  0.015
 Mean tacrolimus count  24.71+/-13.84  20.31+/-14.95  0.078

**Tacrolimus levels were taken from 6 months up until rejection in the rejection cases or matched time points in the controls.

Conclusion

This study shows that high IPV and lower minimum tacrolimus levels predict late first episode rejection. This analysis supports the need for a prospective study to assess strategies which minimise nonadherence, reduce the variability of tacrolimus levels, maintain patients within the therapeutic range of tacrolimus and reduce the risk of development of late rejection and graft loss.

CITATION INFORMATION: Goodall D, Willicombe M, McLean A, Taube D. Late Renal Allograft Rejection Is Predicted by High Intrapatient Variability of Tacrolimus Levels. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Goodall D, Willicombe M, McLean A, Taube D. Late Renal Allograft Rejection Is Predicted by High Intrapatient Variability of Tacrolimus Levels. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/late-renal-allograft-rejection-is-predicted-by-high-intrapatient-variability-of-tacrolimus-levels/. Accessed April 16, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.